Pfizer-BioNTech Vaccine Recall

With the click of a button, The Identifier System could have quickly tracked and traced the origin of the Pfizer-BioNTech vaccine defects and its distribution trail.

On March 23, 2021, Hong Kong puts a stop on distributing the Pfizer-BioNTech Vaccine to residents.  Many containers were flawed among a batch of 585,000 doses due to packaging defects on the vaccine.  There were reports of leaks, loose caps, cracks and stains on the containers.  From this batch, 150,200 people received the shot before the recall was in action.  Batch number 210102 is in the process of tracing back to the manufacturing origin of where the product was created and packaged.

The Identifier System will significantly improve informed product acceptance or rejection decisions. This expert system is the first to fill the defect monitoring gap across the visual inspection, particulate and physical defect control lifecycle of sterile products and devices. The digital platform consolidates defect management and inspection qualification data meeting cGMP regulatory expectations. Process data is readily available, in real time, to authorized users, manufacturing and quality personnel across an organization..

Although, it is believed that this defect did not have any health concerning safety issues, they still put an additional lot (batch 210104) on hold for precautionary measures and ensure the safety of the vaccine before distributing to the residents again. This mistake is still unclear of how long it will take to clear up.  Hong Kong has concerns that not all of the residents will be able to receive the vaccine due to the amount of product that has been recalled.

To learn more about the recall, click the links below:

Comments are closed.